Diminished retinal complex lipid synthesis and impaired fatty acid β-oxidation associated with human diabetic retinopathy
Patrice E Fort, Thekkelnaycke M Rajendiran, Tanu Soni, Jaeman Byun, Yang Shan, Helen C Looker, Robert G Nelson, Matthias Kretzler, George Michailidis, Jerome E Roger, Thomas W Gardner, Steven F Abcouwer, Subramaniam Pennathur, Farsad Afshinnia, Patrice E Fort, Thekkelnaycke M Rajendiran, Tanu Soni, Jaeman Byun, Yang Shan, Helen C Looker, Robert G Nelson, Matthias Kretzler, George Michailidis, Jerome E Roger, Thomas W Gardner, Steven F Abcouwer, Subramaniam Pennathur, Farsad Afshinnia
Abstract
BACKGROUNDThis study systematically investigated circulating and retinal tissue lipid determinants of human diabetic retinopathy (DR) to identify underlying lipid alterations associated with severity of DR.METHODSRetinal tissues were retrieved from postmortem human eyes, including 19 individuals without diabetes, 20 with diabetes but without DR, and 20 with diabetes and DR, for lipidomic study. In a parallel study, serum samples from 28 American Indians with type 2 diabetes from the Gila River Indian Community, including 12 without DR, 7 with mild nonproliferative DR (NPDR), and 9 with moderate NPDR, were selected. A mass-spectrometry-based lipidomic platform was used to measure serum and tissue lipids.RESULTSIn the postmortem retinas, we found a graded decrease of long-chain acylcarnitines and longer-chain fatty acid ester of hydroxyl fatty acids, diacylglycerols, triacylglycerols, phosphatidylcholines, and ceramide(NS) in central retina from individuals with no diabetes to those with diabetes with DR. The American Indians' sera also exhibited a graded decrease in circulating long-chain acylcarnitines and a graded increase in the intermediate-length saturated and monounsaturated triacylglycerols from no DR to moderate NPDR.CONCLUSIONThese findings suggest diminished synthesis of complex lipids and impaired mitochondrial β-oxidation of fatty acids in retinal DR, with parallel changes in circulating lipids.TRIAL REGISTRATIONClinicalTrials.gov NCT00340678.FUNDINGThis work was supported by NIH grants R24 DK082841, K08DK106523, R03DK121941, P30DK089503, P30DK081943, P30DK020572, P30 EY007003; The Thomas Beatson Foundation; and JDRF Center for Excellence (5-COE-2019-861-S-B).
Keywords: Diabetes; Fatty acid oxidation; Ophthalmology; Retinopathy.
Conflict of interest statement
Conflict of interest: The authors have declared that no conflict of interest exists.
Figures
References
- Duh EJ, et al. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight. 2017;2(14):93751.
- Yau JW, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi: 10.2337/dc11-1909.
- Zhang X, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649–656. doi: 10.1001/jama.2010.1111.
- Diabetes Control Complications Trial Research Group. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. doi: 10.1056/NEJM199309303291401.
- Eid S, et al. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia. 2019;62(9):1539–1549. doi: 10.1007/s00125-019-4959-1.
- Afshinnia F, et al. Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians. JCI Insight. 2019;4(21):130317.
- Sas KM, et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. JCI Insight. 2016;1(15):86976.
- National Eye Institute. Diabetic Retinopathy. Accessed September 2, 2021.
- Curovic VR, et al. Circulating metabolites and lipids are associated to diabetic retinopathy in individuals with type 1 diabetes. Diabetes. 2020;69(10):2217–2226. doi: 10.2337/db20-0104.
- Ibrahim AS, et al. A lipidomic screen of hyperglycemia-treated HRECs links 12/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase. J Lipid Res. 2015;56(3):599–611. doi: 10.1194/jlr.M056069.
- Koehrer P, et al. Erythrocyte phospholipid and polyunsaturated fatty acid composition in diabetic retinopathy. PLoS One. 2014;9(9):e106912. doi: 10.1371/journal.pone.0106912.
- Sas KM, et al. Shared and distinct lipid-lipid interactions in plasma and affected tissues in a diabetic mouse model. J Lipid Res. 2018;59(2):173–183. doi: 10.1194/jlr.M077222.
- Schwartzman ML, et al. Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy. Diabetes. 2010;59(7):1780–1788. doi: 10.2337/db10-0110.
- Xuan Q, et al. Rapid lipidomic profiling based on ultra-high performance liquid chromatography-mass spectrometry and its application in diabetic retinopathy. Anal Bioanal Chem. 2020;412(15):3585–3594. doi: 10.1007/s00216-020-02632-6.
- Tikhonenko M, et al. Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes. 2010;59(1):219–227. doi: 10.2337/db09-0728.
- O’Brien PD, et al. Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes. Dis Model Mech. 2020;13(2):dmm042101.
- Weil EJ, et al. Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes. Diabetes. 2013;62(9):3224–3231. doi: 10.2337/db12-1512.
- Silva PS, et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology. 2015;122(5):949–956. doi: 10.1016/j.ophtha.2015.01.008.
- Shimizu K, et al. Midperipheral fundus involvement in diabetic retinopathy. Ophthalmology. 1981;88(7):601–612. doi: 10.1016/S0161-6420(81)34983-5.
- van der Veen JN, et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2017;1859(9 Pt B):1558–1572.
- Afshinnia F, et al. Plasma lipidomic profiling identifies a novel complex lipid signature associated with ischemic stroke in chronic kidney disease. J Transl Sci. 2020;6(6):419.
- Rajagopal R, et al. Retinal de novo lipogenesis coordinates neurotrophic signaling to maintain vision. JCI Insight. 2018;3(1):97076.
- Fox TE, et al. Diabetes diminishes phosphatidic acid in the retina: a putative mediator for reduced mTOR signaling and increased neuronal cell death. Invest Ophthalmol Vis Sci. 2012;53(11):7257–7267. doi: 10.1167/iovs.11-7626.
- Fox TE, et al. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy. Diabetes. 2006;55(12):3573–3580. doi: 10.2337/db06-0539.
- Gorusupudi A, et al. Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers. J Lipid Res. 2016;57(3):499–508. doi: 10.1194/jlr.P065540.
- Enticknap JB. Lipids in cadaver sera after fatal heart attacks. J Clin Pathol. 1961;14:496–499. doi: 10.1136/jcp.14.5.496.
- Montanini L, et al. Human RNA integrity after postmortem retinal tissue recovery. Ophthalmic Genet. 2013;34(1-2):27–31. doi: 10.3109/13816810.2012.720342.
- Mozetic V, et al. Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:92.
- Fonda SJ, et al. The Indian Health Service Primary Care-Based Teleophthalmology Program for diabetic eye disease surveillance and management. Telemed J E Health. 2020;26(12):1466–1474. doi: 10.1089/tmj.2019.0281.
- [No authors listed] Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):786–806.
- Ruebsam A, et al. A specific phosphorylation regulates the protective role of αA-crystallin in diabetes. JCI Insight. 2018;3(4):97919.
- Afshinnia F, et al. Lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort. Kidney Int Rep. 2016;1(4):256–268. doi: 10.1016/j.ekir.2016.08.007.
- Afshinnia F, et al. Impaired β-oxidation and altered complex lipid fatty acid partitioning with advancing CKD. J Am Soc Nephrol. 2018;29(1):295–306. doi: 10.1681/ASN.2017030350.
- Abcouwer SF, et al. Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury. J Neuroinflammation. 2013;10:149.
Source: PubMed